~6,000 high-risk patients monitored between visits
Continuous monitoring of high-risk patients turned a low-frequency snapshot into an early-warning signal, and moved activity out of the emergency pathway.
Continuous monitoring of high-risk patients turned a low-frequency snapshot into an early-warning signal, and moved activity out of the emergency pathway.
Screening at a visit patients were already making, the same opportunistic model Docomed brings to routine primary care.
“I'm keen to support you in any way I can.”
Clinical engagement
Docomed is building its evidence base through partnerships with clinical innovators and active pilot programmes.
Director of the Center for Device Innovation at the Texas Medical Center, a supporter of Docomed's development and route into the TMC ecosystem.
Houston Methodist and Baylor St Luke's, running a clinical pilot across several clinics to capture cardiac data sets that strengthen the platform's machine-learning analytics.
Named clinical partners and quotations are shown with their permission; further validation from healthcare leaders will be added as programmes report.
We’re happy to walk your clinical or evaluation team through the underlying data.
Or email us directly at enquiries@docomed.ai